Chlamydia Infection and Heavy Bleeding
Chlamydia trachomatis infection can cause heavy menstrual bleeding, though it is not the most common presentation of this infection. The mechanism is through endometritis (inflammation of the uterine lining), which disrupts normal menstrual patterns and can manifest as abnormal uterine bleeding, including menorrhagia.
Evidence Linking Chlamydia to Heavy Bleeding
The connection between chlamydia and abnormal bleeding is well-documented in the research literature:
A 2007 study found chlamydia in 48% of women presenting with abnormal uterine bleeding 1, which is substantially higher than typical population prevalence. This suggests a meaningful association between the infection and bleeding abnormalities.
Clinical presentations include irregular bleeding (26% of infected women), menorrhagia, metrorrhagia, and breakthrough bleeding 2, 3. The bleeding occurs because chlamydia causes endometritis with characteristic plasma cell infiltration of the endometrium 4.
Women with chlamydial endometritis frequently present with irregular bleeding as a manifestation of upper genital tract infection 4.
Clinical Approach
When evaluating a sexually active woman of reproductive age with heavy menstrual bleeding, consider chlamydia if she has:
- Age <25 years (highest risk group per all CDC guidelines 5, 6, 7, 5)
- New or multiple sexual partners
- Inconsistent barrier contraceptive use
- History of prior STIs
- Accompanying symptoms: pelvic pain (46% of symptomatic cases), vaginal discharge (39%), or postcoital bleeding 3
Important caveat: Most chlamydial infections are asymptomatic 5, 8, 9. The absence of typical STI symptoms does not exclude chlamydia as a cause of abnormal bleeding.
Diagnostic Strategy
Test all sexually active women with abnormal uterine bleeding for chlamydia using nucleic acid amplification tests (NAATs), which are the most sensitive and specific diagnostic tools 10, 11. Testing can be performed on:
- Cervical swabs
- Vaginal swabs (including self-collected)
- Urine specimens
The presence of macrophages on endometrial histology is a strong predictor of chlamydial endometritis (area under ROC curve = 0.82) 1.
Treatment Recommendations
If chlamydia is detected, treat immediately per CDC guidelines 7, 5:
First-line options:
- Azithromycin 1 g orally as a single dose, OR
- Doxycycline 100 mg orally twice daily for 7 days
Key management points:
- Abstain from intercourse for 7 days after single-dose therapy or until completion of 7-day regimen 7
- Treat all sexual partners from the preceding 60 days 7, 5
- Retest in 3 months due to high reinfection rates (up to 39% in young women) 5, 12
Critical Pitfalls to Avoid
Don't assume normal pelvic exam excludes chlamydia - Many women with cervical infection already have subclinical upper tract disease 5, 8
Don't overlook partner treatment - Failure to treat partners leads to reinfection and continued bleeding symptoms 7
Don't dismiss bleeding as "just hormonal" in young sexually active women without STI testing - The prevalence of chlamydia in women with abnormal bleeding is substantially elevated 1
Screen before procedures - In women undergoing therapeutic abortion, 19% of chlamydia carriers developed morbidity 3
Long-term Implications
Untreated chlamydial endometritis can ascend to cause pelvic inflammatory disease, which carries serious sequelae 5, 8, 13:
- Infertility (10-20% of PID cases)
- Ectopic pregnancy
- Chronic pelvic pain
- Increased risk with repeat infections 5
The bottom line: While chlamydia more commonly presents asymptomatically or with discharge and pelvic pain, it is a recognized cause of heavy and irregular bleeding through endometritis. All sexually active women with abnormal uterine bleeding should be tested for chlamydia, particularly those under 25 or with other risk factors.